JPRN-UMIN000037478已完成未知
Evaluation of pathophysiology of cancer based on HLA and APRs. - Japan cancer treatment and behavior study group (JCTB study)
Japan cancer treatment and behavior study group (JCTB)0 个研究点目标入组 967 人开始时间: 2019年7月29日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 967
研究概览
简要总结
The frequencies of HLA A33, B44, Cw3, DR6, DR8, DR9 and DQ4 antigens were lower in total; therefore, these antigens may act as defensive factors of carcinogenesis.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •not particular
研究者
相似试验
招募中
不适用
Assessing Frequency of HLA-Genotype and Tumor Antigen Expression in Subjects with Relapsed/Refractory, Advanced-Stage Solid Tumors that may Qualify for Novel T Cell Receptor Based TherapiesNL-OMON53305T-knife GmbH400
已完成
2 期
Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older AdultsGraft vs Host DiseaseMyeloid LeukemiaLeukemiaMyelodysplastic SyndromeChronic Lymphocytic LeukemiaNCT00001637National Heart, Lung, and Blood Institute (NHLBI)28
Unknown
不适用
Allogeneic HCT Using Uniform Conditioning Regimen Regardless of Donors (MS, MU, or HF) for AML in RemissionAcute Myeloid LeukemiaNCT03337568Asan Medical Center110
已完成
不适用
Human Leukocyte Antigen Typing and Tumor Antigen Expression ProfilingRefractory CancerRecurrent CancerAdult Solid TumorNeoplasmsNCT03760952Immatics US, Inc.242
Unknown
不适用
Tumor Response in Hypofractionated RadiotherapyNeoplasmsNCT02854449Peking University First Hospital30
